By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company HeartSciences Inc.

HeartSciences Inc. (HSCS)

NASDAQ Currency in USD
$175.00
-$3.30
-1.85%
Last Update: 19 Jul 2026, 10:50
$0.00
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$123.09-$216.10
52 Week Range

HSCS Stock Price Chart

Explore HeartSciences Inc. interactive price chart. Choose custom timeframes to analyze HSCS price movements and trends.

HSCS Company Profile

Discover essential business fundamentals and corporate details for HeartSciences Inc. (HSCS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

16 Jun 2022

Employees

15.00

CEO

Andrew Simpson

Description

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

HSCS Financial Timeline

Browse a chronological timeline of HeartSciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Jul 2026

EPS estimate is -$0.66, while revenue estimate is $50.00k.

Earnings released on 16 Mar 2026

EPS came in at -$0.63 surpassing the estimated -$0.84 by +25.00%.

Earnings released on 15 Dec 2025

EPS came in at -$0.85 surpassing the estimated -$0.90 by +5.56%, while revenue for the quarter reached $2.42k .

Earnings released on 11 Sept 2025

EPS came in at -$1.58 surpassing the estimated -$2.41 by +34.44%, while revenue for the quarter reached $1.90k .

Earnings released on 24 Jul 2025

EPS came in at -$1.88 surpassing the estimated -$2.51 by +25.10%, while revenue for the quarter reached $4.35k .

Earnings released on 13 Mar 2025

EPS came in at -$2.57 falling short of the estimated -$2.53 by -1.58%.

Earnings released on 16 Dec 2024

EPS came in at -$2.27 surpassing the estimated -$2.30 by +1.30%.

Earnings released on 12 Sept 2024

EPS came in at -$2.64 falling short of the estimated -$2.46 by -7.32%.

Earnings released on 29 Jul 2024

EPS came in at -$18.81 falling short of the estimated -$3.50 by -437.43%.

Stock split effective on 17 May 2024

Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 14 Mar 2024

EPS came in at -$3.00 falling short of the estimated -$0.06 by -4.90k%, while revenue for the quarter reached $14.70k .

Earnings released on 14 Dec 2023

EPS came in at -$16.00 falling short of the estimated -$0.12 by -13.23k%, while revenue for the quarter reached $3.90k .

Earnings released on 14 Sept 2023

EPS came in at -$13.00 falling short of the estimated -$0.14 by -9.19k%.

Earnings released on 18 Jul 2023

EPS came in at -$16.00 falling short of the estimated -$0.16 by -9.90k%.

Earnings released on 16 Mar 2023

EPS came in at -$16.00 falling short of the estimated -$0.16 by -9.90k%, while revenue for the quarter reached $1.95k , beating expectations by +95.00%.

Earnings released on 15 Dec 2022

EPS came in at -$22.00 falling short of the estimated -$0.33 by -6.57k%.

Earnings released on 12 Sept 2022

EPS came in at -$0.28 surpassing the estimated -$28.00 by +99.00%, while revenue for the quarter reached $3.20k , beating expectations by +6.67%.

Earnings released on 29 Jul 2022

EPS came in at -$61.77 , while revenue for the quarter reached $4.15k .

Earnings released on 31 Jan 2022

EPS came in at -$37.27 , while revenue for the quarter reached $2.74k .

Earnings released on 31 Oct 2021

EPS came in at -$31.23 .

Earnings released on 31 Jul 2021

EPS came in at -$15.14 , while revenue for the quarter reached $7.48k .

HSCS Stock Performance

Access detailed HSCS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run